More NewsCFO leaves biotechnology company

CFO leaves biotechnology company

Silence finance chief steps down

The chief financial officer of
Silence
Therapeutics
has resigned.

Melvyn Davies, who was also company secretary, had been with Silence for 15
years. He will assist the company for up to three months until they find a
successor.

Silence, which specialises in treating serious diseases with biotechnology,
also announced the resignation of Iain Ross, chairman and a director of the
board. The board has appointed Jerry Randall, senior independent director, to
replace him.

Randall said: “I would like to extend my own and the board’s heartfelt thanks
to both Iain and Melvyn for all they have contributed to Silence.”

Further reading:

Female
accountants paid 60% less than men

Davis
Service Group swoops for board finance experts

Smiths
FD retires after 28 years

Related Articles

Amazon UK halves its corporation tax bill despite increased turnover

More News Amazon UK halves its corporation tax bill despite increased turnover

4m Alia Shoaib, Reporter
Increase in UK business confidence despite Brexit, according to ICAEW

More News Increase in UK business confidence despite Brexit, according to ICAEW

7m Alia Shoaib, Reporter
Live blog: Spring Budget 2017

Corporate Tax Live blog: Spring Budget 2017

9m Accountancy Age editorial
The Curious Incident of the Insolvency Sector in the Light of Economic Turbulence

Insolvency The Curious Incident of the Insolvency Sector in the Light of Economic Turbulence

11m Accountancy Age editorial
Leonard Curtis called in as administrators for builders Boshers

Legal Leonard Curtis called in as administrators for builders Boshers

11m Stephanie Wix, Writer
New Year Honours of 2017

Accounting Standards New Year Honours of 2017

11m Stephanie Wix, Writer
"Not enough time" to implement MTD by 2018, says Tyrie

Corporate Tax "Not enough time" to implement MTD by 2018, says Tyrie

1y Stephanie Wix, Writer
Colin: A spoonful of investment...

Governance Colin: A spoonful of investment...

1y Stephanie Wix, Writer